Close Menu

NEW YORK — Becton Dickinson on Thursday priced its previously announced offerings of $3 billion in public stock and depository shares.

The Franklin Lakes, New Jersey-based medical supplies and diagnostics company said it is offering $1.5 billion of common stock at $240 per share. It is also offering $1.5 billion of depositary shares, which represent 1/20th interest in a share of 6.00 percent mandatory convertible preferred stock, Series B, at $50 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.